FSMDX
Price
$37.08
Change
-$0.05 (-0.13%)
Updated
Sep 15 closing price
Net Assets
44.83B
TQSMX
Price
$24.78
Change
-$0.06 (-0.24%)
Updated
Sep 15 closing price
Net Assets
847.81M
Interact to see
Advertisement

FSMDX vs TQSMX

Header iconFSMDX vs TQSMX Comparison
Open Charts FSMDX vs TQSMXBanner chart's image
Fidelity Mid Cap Index
Price$37.08
Change-$0.05 (-0.13%)
VolumeN/A
Net Assets44.83B
T. Rowe Price Integrated US SMCC Eq
Price$24.78
Change-$0.06 (-0.24%)
VolumeN/A
Net Assets847.81M
FSMDX vs TQSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. TQSMX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and TQSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 44.8B vs. TQSMX (848M). FSMDX pays higher dividends than TQSMX: FSMDX (1.26) vs TQSMX (0.52). FSMDX was incepted earlier than TQSMX: FSMDX (14 years) vs TQSMX (10 years). TQSMX (0.90) is less costly to investors than FSMDX (0.03). TQSMX is a more actively managed with annual turnover of: 52.60 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than TQSMX: FSMDX (0) vs TQSMX (2500). FSMDX annual gain was more profitable for investors over the last year : 12.83 vs. TQSMX (6.54). FSMDX (70.60) and TQSMX (68.66) have equivalent 5 years return.
FSMDXTQSMXFSMDX / TQSMX
Total Expense Ratio0.030.873%
Annual Report Gross Expense Ratio0.030.903%
Fund Existence14 years10 years-
Gain YTD10.2169.814104%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets44.8B848M5,283%
Annual Yield % from dividends1.260.52240%
Returns for 1 year12.836.54196%
Returns for 3 years48.3139.06124%
Returns for 5 years70.6068.66103%
Returns for 10 years142.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNSE9.020.04
+0.47%
Sensei Biotherapeutics Inc
SSNC88.74-0.47
-0.53%
SS&C Technologies Holdings
KAR28.60-0.28
-0.97%
OPENLANE
ACDC3.71-0.04
-1.07%
ProFrac Holding Corp
CGTX1.54-0.63
-29.03%
Cognition Therapeutics